5-ht7 receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 217/04 (2006.01) A61K 31/47 (2006.01) A61K 31/4725 (2006.01) A61P 25/00 (2006.01) C07D 401/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01) C07D 513/04 (2006.01)

Patent

CA 2575785

The invention relates to compounds of formula (I) having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5- HT is involved, such as CNS disorders.

L'invention concerne des composés de formule (I) à activité pharmacologique vis-à-vis du récepteur 5-HT7, et plus précisément de certains composés tétrahydroisoquinoline propyl sulfonamide, des procédés d'élaboration de tels composés, des compositions pharmaceutiques qui les renferment, et leur utilisation pour le traitement et la prophylaxie d'une maladie faisant intervenir le 5-HT, du type trouble du système nerveux central.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

5-ht7 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-ht7 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-ht7 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1525972

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.